Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Nuclear Medicine Communications
|
March 1, 1994
Contraindications in the administration of 99Tcm-labelled macroaggregates or microspheres of albumin--any basis?
A A Bolster, T Murray, T E Hilditch
Nuclear Medicine Communications
|
May 1, 1988
Automated radiopharmaceutical dispensing
A T Elliott, T Murray, T E Hilditch
Journal of Clinical and Hospital Pharmacy
|
March 1, 1984
Microbial contamination of pharmaceutical injections at the site of administration
W Whyte, T E Hilditch, N D Bell
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 16, 1975
Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy
W H Thomson, J C Sweetin, T E Hilditch
The British Journal of Ophthalmology
|
November 1, 1983
Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora
L A Amanat, T E Hilditch, C S Kwok
Lancet (London, England)
|
March 3, 1979
Minimum effective dose of carbimazole
L C Low, T E Hilditch, W D Alexander
Physics in Medicine and Biology
|
November 1, 1980
Monitoring of airborne contamination during the handling of technetium-99m and radioiodine
A S Eadie, P W Horton, T E Hilditch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1995
Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG
A A Bolster, T E Hilditch, T E Wheldon
Lancet (London, England)
|
August 11, 1973
Rubidium and detection of Duchenne carriers
T E Hilditch, J C Sweetin, W H Thomson
The British Journal of Ophthalmology
|
November 1, 1983
Lacrimal scintigraphy. III. Physiological aspects of lacrimal drainage
L A Amanat, T E Hilditch, C S Kwok
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Nuclear Medicine Communications
|
March 1, 1994
Contraindications in the administration of 99Tcm-labelled macroaggregates or microspheres of albumin--any basis?
A A Bolster, T Murray, T E Hilditch
Nuclear Medicine Communications
|
May 1, 1988
Automated radiopharmaceutical dispensing
A T Elliott, T Murray, T E Hilditch
Journal of Clinical and Hospital Pharmacy
|
March 1, 1984
Microbial contamination of pharmaceutical injections at the site of administration
W Whyte, T E Hilditch, N D Bell
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 16, 1975
Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy
W H Thomson, J C Sweetin, T E Hilditch
The British Journal of Ophthalmology
|
November 1, 1983
Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora
L A Amanat, T E Hilditch, C S Kwok
Lancet (London, England)
|
March 3, 1979
Minimum effective dose of carbimazole
L C Low, T E Hilditch, W D Alexander
Physics in Medicine and Biology
|
November 1, 1980
Monitoring of airborne contamination during the handling of technetium-99m and radioiodine
A S Eadie, P W Horton, T E Hilditch
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1995
Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG
A A Bolster, T E Hilditch, T E Wheldon
Lancet (London, England)
|
August 11, 1973
Rubidium and detection of Duchenne carriers
T E Hilditch, J C Sweetin, W H Thomson
The British Journal of Ophthalmology
|
November 1, 1983
Lacrimal scintigraphy. III. Physiological aspects of lacrimal drainage
L A Amanat, T E Hilditch, C S Kwok
Page
of 8